Dudediligence.

Immunome, Inc

IMNMNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$18.7M

15 notices · 834,948 sh

Jan 3 to Oct 4

Reported ·

$12.6M

10 sales · 11 buys · $2,305,990 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

6 of 10 reported sales carry the 10b5-1 box. Together they are 0.52% of the shares on issue.

PLANNED · FORM 144Jan 3 to Oct 4REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-11: Higgins Jack, Form 1442026-08-12: Barchas Isaac, Form 1442026-08-06: ABHMC II, LLC, Form 1442026-08-04: Horn Kinney, Form 1442026-07-07: Horn Kinney, Form 1442026-07-06: ABHMC II, LLC, Form 1442026-07-02: Lechleider Robert, Form 1442026-07-02: ABHMC II, LLC, Form 1442026-06-30: ABHMC II, LLC, Form 1442026-06-30: Arsenal Bridge Venture II-B, LLC, Form 1442026-06-25: Lechleider Robert, Form 1442026-06-15: Rosett Max, Form 1442026-04-02: Rosett Max, Form 1442026-04-02: Higgins Jack, Form 1442026-03-20: WAGENHEIM PHILIP, Form 1442025-12-18: SIEGALL CLAY B, bought2025-12-19: SIEGALL CLAY B, bought2025-12-19: Tsai Philip, bought2025-12-22: Barchas Isaac, sold2025-12-30: SIEGALL CLAY B, bought2026-03-10: BIENAIME JEAN JACQUES, bought2026-03-20: WAGENHEIM PHILIP, sold2026-03-27: SIEGALL CLAY B, bought2026-04-02: Higgins Jack, sold2026-04-02: Rosett Max, sold2026-05-15: BIENAIME JEAN JACQUES, bought2026-06-05: BIENAIME JEAN JACQUES, sold2026-06-05: BIENAIME JEAN JACQUES, bought2026-06-15: Rosett Max, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-11Higgins Jack, Chief Scientific Officer$334,224
13,200 shplan 2025-12-19Form 4s on file end Jun 23144 ↗
2026-08-12Barchas Isaac, Director$301,058
11,048 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-08-06ABHMC II, LLC, Shareholder$2,769,022
108,504 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-08-04Horn Kinney, CHIEF BUSINESS OFFICER$2,274,007
90,616 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-07-07Horn Kinney, CHIEF BUSINESS OFFICER$27,300
1,092 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-07-06ABHMC II, LLC, Shareholder$2,361,000
100,000 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-07-02Lechleider Robert, Chief Medical Officer$1,188,000
55,000 shplan 2026-03-26Form 4s on file end Jun 23144 ↗
2026-07-02ABHMC II, LLC, Shareholder$2,149,000
100,000 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-06-30ABHMC II, LLC, Shareholder$2,104,000
100,000 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-06-30Arsenal Bridge Venture II-B, LLC, Shareholder$22,092
1,050 shplan 2026-03-31Form 4s on file end Jun 23144 ↗
2026-06-25Lechleider Robert, Chief Medical Officer$1,085,150
55,000 shplan 2026-03-26144 ↗
Form 4, 2026-06-29: sold 55,000 at $19.85 Form 4 ↗
2026-06-15Rosett Max, Chief Financial Officer$1,117,800
60,000 shplan 2025-12-26144 ↗
Form 4, 2026-06-17: sold 60,000 at $18.23 Form 4 ↗
2026-04-02Rosett Max, Chief Financial Officer$1,425,085
65,000 shplan 2025-12-26144 ↗
Form 4, 2026-04-03: sold 65,000 at $21.92 Form 4 ↗
2026-04-02Higgins Jack, Chief Scientific Officer$204,238
9,438 shplan 2025-12-19144 ↗
Form 4, 2026-04-03: sold 9,438 at $21.64 Form 4 ↗
2026-03-20WAGENHEIM PHILIP, Director$1,352,640
65,000 shno plan date144 ↗
Form 4, 2026-03-23: sold 65,000 at $20.55 Form 4 ↗